Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TRDA | Entrada Therapeutics | $0.68 | -$0.72 | — | — | $59.12M | $11.95M | — | — | 05/20/2025 | Get Alert |
TRDA | Entrada Therapeutics | -$0.29 | -$0.66 | $0.03 | 104.55% | $41.85M | $12.92M | $37.40M | 189.46% | 02/27/2025 | Get Alert |
TRDA | Entrada Therapeutics | $1.02 | -$0.73 | -$0.35 | 52.05% | $43.73M | $12.32M | $19.57M | 58.85% | 11/05/2024 | Get Alert |
TRDA | Entrada Therapeutics | -$0.78 | $0.14 | $1.55 | 1007.14% | $18.17M | $46.07M | $94.69M | 105.54% | 08/13/2024 | Get Alert |
TRDA | Entrada Therapeutics | -$0.21 | -$0.59 | $0.68 | 215.25% | $25.26M | $14.98M | $59.12M | 294.66% | 05/07/2024 | Get Alert |
TRDA | Entrada Therapeutics | -$0.79 | -$0.17 | -$0.29 | -70.59% | $0.00 | $23.69M | $41.85M | 76.65% | 03/13/2024 | Get Alert |
TRDA | Entrada Therapeutics | -$0.80 | -$0.74 | $1.02 | 237.84% | $0.00 | $9.60M | $43.73M | 355.57% | 11/07/2023 | Get Alert |
TRDA | Entrada Therapeutics | -$0.74 | — | -$0.78 | — | $0.00 | — | $18.17M | — | 08/08/2023 | Get Alert |
TRDA | Entrada Therapeutics | -$0.69 | — | -$0.21 | — | $0.00 | — | $25.26M | — | 05/10/2023 | Get Alert |
TRDA | Entrada Therapeutics | -$0.89 | -$0.83 | -$0.79 | 4.82% | $0.00 | — | $0.00 | — | 03/06/2023 | Get Alert |
TRDA | Entrada Therapeutics | -$9.78 | -$0.76 | -$0.80 | -5.26% | $0.00 | — | $0.00 | — | 11/07/2022 | Get Alert |
TRDA | Entrada Therapeutics | -$7.56 | — | -$0.74 | — | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
TRDA | Entrada Therapeutics | -$6.67 | — | -$0.69 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
TRDA | Entrada Therapeutics | -$7.47 | — | -$0.89 | — | $0.00 | — | $0.00 | — | 03/15/2022 | Get Alert |
TRDA | Entrada Therapeutics | -$6.13 | — | -$9.78 | — | $0.00 | — | $0.00 | — | 12/09/2021 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.03 | $-0.66 | 104.6 % |
Q3 | 2024-11-05 | $-0.35 | $-0.73 | 52.0 % |
Q2 | 2024-08-13 | $1.55 | $0.14 | 1007.1 % |
Q1 | 2024-05-07 | $0.68 | $-0.59 | 215.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $37.40M | $12.92M | 189.5 % |
Q3 | 2024-11-05 | $19.57M | $12.32M | 58.9 % |
Q2 | 2024-08-13 | $94.69M | $46.07M | 105.5 % |
Q1 | 2024-05-07 | $59.12M | $14.98M | 294.7 % |
Entrada Therapeutics (TRDA) is scheduled to report earnings on May 20, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.03, which beat the estimate of $-0.66.
The Actual Revenue was $37.4M, which beat the estimate of $12.9M.
Browse earnings estimates, EPS, and revenue on all stocks.